Studying transitions in and out of the altered state of consciousness caused by intravenous (IV) N,N-Dimethyltryptamine (DMT -a fast-acting tryptamine psychedelic) offers a safe and powerful means of advancing knowledge on the neurobiology of conscious states. Here we sought to investigate the effects of IV DMT on the power spectrum and signal diversity of human brain activity (6 female, 7 male) recorded via multivariate EEG, and plot relationships between subjective experience, brain activity and drug plasma concentrations across time. Compared with placebo, DMT markedly reduced oscillatory power in the alpha and beta bands and robustly increased spontaneous signal diversity.
Introduction
N, N, Dimethyltryptamine (DMT) is a naturally-occurring serotonergic psychedelic 1 that is capable of producing experiences that, in intensity, surpass those associated with standard doses of most orally administered psychedelics and indeed most other categories of psychoactive drugs 2, 3 . The subjective effects of intravenous DMT have a rapid onset that is characterized by unusually vivid visual imagery and somatic effects, which arise within seconds of the injection. At high doses, the experience rapidly progresses into a deep and profound immersion -sometimes described as a 'breakthrough'. This experience is often characterized by a sense of entering into an entirely 'other' but no less 'real' world or dimension 3, 4 . It is not uncommon for people to describe encounters with sentient 'entities' or 'presences' within this perceived other world 4, 5 and for the experience to subsequently challenge beliefs about the nature of reality and consciousness.
The phenomenology of the DMT experience suggests it may be an especially powerful scientific tool for illuminating the neurobiology of consciousness. DMT experiences can be said to resemble 'worldanalogue' experiences (i.e. interior analogues of external worlds) -similar to the dream state 6 . It is logical to presume that conscious processing becomes 'functionally deafferented' (i.e. cut-off) from the external sensorium in these states, paralleled by what is presumably an entirely internally generated 'simulation state', felt as entry into an entirely other world 5 . The rapid, short-acting and dramatic subjective effects of intravenous DMT therefore render it well-suited for investigating the neurobiology of consciousness with functional brain imaging -and this is what we sought to exploit here.
Previous EEG and magnetoencephalography (MEG) studies of psychedelic-induced changes in brain activity have yielded generally consistent results. Broadband decreases in (absolute) oscillatory power have been seen with psilocybin 7 , LSD 8 , and (the DMT-containing ceremonial brew) ayahuasca 9 . Brain imaging measures of the complexity, diversity, or entropy of brain activity have been used to index the quality of a range of different conscious states [10] [11] [12] and MEG studies have shown this to be increased after the administration of a range of psychedelics 13 . Recent advances in analytical methods have allowed for the decomposition of spectral power into its oscillatory and fractal (1/f) components 14 and these components are thought to have distinct functional relevancies 15 .
Moreover, as has been shown to be the case with other atypical states of consciousness 14 psychedelics appear to affect 1/f-related activity 16, 17 . Here, we sought to disentangle the specific relationships between different spectral components and different aspects of the DMT experience.
Considering the fast-acting effects of DMT and the well-known effect that psychedelics have on vascular activity 1 (which may be confounded with neuronal activity when using functional Magnetic Resonance Imaging; fMRI 18 ), we opted to use the EEG as technique which has optimal temporal resolution and is a more direct measure of neural activity.
The primary aim of our study was to determine the effects of a bolus intravenous injection of DMT (versus a bolus intravenous injection of saline) on the power spectrum and signal diversity of EEG recorded brain activity. Further, we aimed to establish the relationship between these brain activity measures, the real-time progression of the subjective experience and parallel changes in plasma levels of DMT. Finally, both conventional psychometric analyses and more temporally finessed methodsinspired by neurophenomenology 19 -were utilized to assist the process of mapping between brain and experience. Our primary hypothesis was that DMT would decrease oscillatory power in the alpha band and increase cortical signal diversity and that these effects would correlate with changes in conscious experience across time.
Results

Subjective effects
Participants were asked to provide ratings of the subjective intensity of the drug effects at every minute for a total of 20 minutes after DMT and placebo administration. Figure 1A displays the groupaveraged intensity plots for each minute for a total of 20 minutes post-injection. Paired T-tests revealed that the subjective intensity of the experience remained significantly higher under DMT vs placebo for 17 minutes post-dosing (False Discovery Rate -FDR corrected) and peak subjective effects occurred 2-3 minutes post-injection.
Supplementing these basic intensity ratings, participants were asked to rate different aspects of their experiences using various visual analogue scales (VAS). All items were rated significantly higher in the DMT condition compared with placebo (FDR corrected) ( Figure 1B) . Ratings were given retrospectively, at ~30 minutes following administration, i.e. once the acute effects of DMT had sufficiently subsided. 
Time-averaged EEG results
EEG analyses were done contrasting the group-averaged first 5 minutes of resting state activity following administration of DMT or placebo, focusing on changes in the power spectrum and spontaneous signal diversity (LZs and LZsN). One participant was excluded due to excessive movement artifacts following DMT administration. Supporting one aspect of our primary hypothesis, DMT vs placebo contrasts revealed spatially-widespread and statistically-marked decreases in the alpha band (max. t(11)=-3.87, cluster p=5.33e-04) and more modest decreases in the beta band (max. t(11)=-3.30, cluster p=0.033) ( Figure 2A ). Decomposition analysis of the EEG spectra into oscillatory and fractal (1/f) components aids in separating the contribution of each of these components to EEG activity, which is useful because unlike fractal activity, oscillatory power has well-known neuronal generators and functional relevance. Results for oscillatory power were consistent with those reported above (alpha: max. Results also revealed the emergence of prominent theta oscillations under DMT, to the extent that this rhythm became the peak frequency (i.e. the most pronounced rhythm in terms of power) within the 4 -45 Hz range (mean=7.36 Hz, SEM=0.68) replacing the usually dominant alpha peak ( Figure 2B ). In contrast, the usual dominant alpha peak was maintained throughout the placebo session; mean = 9.28 Hz, SEM=0.62) (t(11) = -2.52, p = 0.029) ( Figure 2C ). The prominence of this emergent theta rhythm was more evident in the oscillatory power spectrum, i.e. once the fractal component had been removed ( Figure 2B The comparison of DMT versus placebo for changes in spectral activity reveals significant decreases for the alpha and beta bands for conventional spectral power. The decomposed spectra into oscillatory and fractal power, revealed similar results for the first and reductions were seen on all bands <30 Hz for the latter. Increases are seen for both measures of spontaneous signal diversity (LZs and LZsN). Filled circles correspond to clusters p<0.01 and hollow circles for clusters p<0.05, N=12. (B) Grand-average spectral power for DMT and placebo corresponding to spectral, oscillatory and fractal (1/f) components of the signal (N=12). (C) Differences (DMT -Placebo) between averaged activity across all channels for the EEG measures displaying the largest effects for each participant before and after injection reveal the decreases in spectral activity and increases in signal diversity for most subjects (N=12) (LZs = Lempel-Ziv complexity, LZsN = normalized LZs).
Time-sensitive EEG results
In addition to consistent alpha and beta reductions, minute-by-minute analysis of the previous results revealed decreases in delta and theta bands for the first minute only -after which recovery (and increases in theta for the oscillatory component) were identified at minutes 2-3 post DMT injection.
These results indicate that DMT induces a general decrease in total power across all frequency bands between 1 and 30 Hz. However, there is a transient normalization/increases in theta and delta frequencies at the time of peak subjective intensity, which is especially evident in the oscillatory component of the signal. The spontaneous signal diversity measure, LZs, was found to be consistently increased for the whole of the post-injection period, and increases in LZsN were evident from the time of peak intensity onwards ( Figure S2 ).
Subjective vs EEG effects across time
In order to assess the relationship between the subjective and EEG changes across time, data was segmented into one minute blocks. Results revealed a negative correlation between changes in total alpha power under DMT and subjective intensity that was significant for all recorded channels (max. 
Plasma DMT vs EEG effects
Here we assessed the relationship between changes in the EEG data (frequency bands and signal diversity) and plasma concentrations of DMT across time. In a similar manner to the subjective values, higher concentrations of DMT in the blood were associated with greater reductions in alpha (max. t(11)=-23.59, cluster p=2.67e-04) and beta power (max. t(11)=-12.61, cluster p=0.04). Similar effects were seen when analyses were performed on the oscillatory component of the signal (alpha: (A) Significant inverse relationships were found between plasma levels of DMT and power in the alpha and beta bands for spectral and oscillatory power, while the relationship was found for plasma DMT and power in the theta band for fractal power. A positive relationship was found between plasma levels of DMT and complexity measures (LZs and LZsN). Filled circles correspond to clusters p<0.01 and hollow circles for clusters p<0.05, N=12. (B) Temporal development of DMT plasma concentrations, and EEG measures of total power and spontaneous signal diversity which were found significant to have a significant effect (mean ± SEM, N=12).
Neurophenomenology
Micro-phenomenological interviews (MPIs) [20] [21] [22] were performed post-hoc to derive distinct components of the subjective experience in a data driven approach -that could then be used to constrain participant ratings referenced to specific time points, i.e. each passing minute. Three major dimensions of experience were found to be common across participants, i.e.: 1) visual, 2) bodily and 3) emotional/metacognitive experiences. These dimensions were extracted from each of the participants' interviews and then rated by a researcher not involved in EEG analysis with reference to each passing minute within the 20-minute recording period ( Figure 5A ).
Adopting a data-led approach, we chose to look at components of the EEG that had already shown interesting relationships with intensity ratings, namely: alpha, beta, delta and theta power, plus signal Average ratings (mean ± SEM) regarding the intensity for the three dimensions of experience which were found to be commonly altered across all participants following DMT administration. (B) Significant inverse relationships were found between the progression of visual effects induced by DMT and power at the alpha and the beta bands, as well as increases in complexity (LZs and LZsN). Decreases of central beta band power showed a significant association the trajectory of bodily effects. Decreases in alpha band power and increases in complexity (LZs and LZsN) were significantly associated to the dynamics emotional/metacognitive effects. Mostly consistent results were found with oscillatory power, however an intriguing positive relationship found with power at delta and theta bands for visual effects and reduced theta activity was linked to emotional/metacognitive effects. Filled circles correspond to clusters p<0.01 and hollow circles for clusters p<0.05, N=11. (C) Radar plots displaying the constellation of EEG effects associated to different dimensions of experience (mean values displayed).
Psychometric correlational analyses
In order to further test the relationship between specific EEG measures and the DMT experience, we performed additional post-hoc 'subjective rating vs EEG' correlations using both time-sensitive (minute-by-minute). Time-sensitive analysis revealed relationships that were broadly consistent with those reported above, i.e. negative correlations were evident between (higher) VAS item scores and (reduced) alpha/beta power and positive correlations were evident between (higher) VAS scores and (increased) LZs/theta/delta -during the period of peak subjective intensity ( Figure 6A) . 
Discussion
This paper presents results from the first ever placebo-controlled investigation of the effects of DMT on spontaneous human brain activity. Immersion into the DMT state was accompanied by marked decreases in total spectral power in alpha and beta bands paralleled by marked increases in spontaneous signal diversity and the emergence of theta and delta oscillations during peak effects.
These effects correlated significantly with the characteristic visual effects of DMT. The increases in delta and theta oscillations were most clearly evident when the oscillatory component was extracted from the fractal component, suggesting that the former is the more functionally relevant component of the signal -at least in relation to these lower frequency bands.
One particularly consistent finding in neuroimaging research with psychedelics is decreased alpha power 7, 8, 23 . Alpha is the most prominent rhythm of the resting-brain, particularly in humans, and particularly in adulthood 24 . Alpha power has been linked with high-level psychological functioning 25, 26 , top-down predictive processing 27, 28 and related feedback connectivity 29 -all of which have been found to be disrupted under serotonergic psychedelics [30] [31] [32] . Serotonin 2A receptor antagonist (ketanserin) pretreatment studies involving both psilocybin 33 and ayahuasca 23, 34 have supported the principle that reduced alpha power under psychedelics depends on their ability to activate 5-HT2A receptors. Here we found strong correlations between alpha power decreases, minute-by-minute changes in the subjective intensity, and DMT levels in plasma.
The present study's findings of profound alpha suppression, combined with normalized/increased delta and theta under DMT may relate to the experience of feeling profoundly immersed in an entirely other world under the drug. The emergence of theta/delta oscillations, particularly in medial temporal lobe sources, has been classically associated with REM sleep dreaming and related 'visionary' states 35, 36 . We propose that the observed emergence of theta/delta rhythmicity combined with the characteristic 'collapse' of alpha/beta rhythmicity under DMT may relate to the 'DMT breakthrough experience' -a perceptual mechanism by which the brain switches from the processing of exogenously incoming information to a state in which processing is endogenously-driven, as in classic REM sleep dreaming 6 . This is further supported by the positive correlation we observed between participants' ratings of the visual quality of their experiences and increases in theta and delta powerand decreases in alpha, especially evident once the (putatively) more functionally relevant oscillatory component of the EEG signal was isolated from the fractal component. Although speculative, it is intriguing to consider that the emergent theta/delta rhythmicity under DMT may have a deep (e.g. medial temporal lobe) source and reflect the recruitment of a circuitry that has been classically associated with REM-sleep and medial temporal lobe stimulation -both of which are known to feature complex visionary phenomena 35 .
The increases in signal diversity found here, as elsewhere 13 may be considered the positive complement of reduced alpha power and are consistent with the so-called 'entropic brain hypothesis' which proposes that within a limited range of states (i.e. within a critical zone) the richness of content of any given conscious state, can be meaningful indexed by the entropy of its underlying spontaneous brain activity 10, 11 . Based on the present study's results, revealing a strong and comprehensive relationship between spontaneous signal diversity (a measure intimately related to entropy 37 ) and the temporal evolution of different aspects of DMT's subjective effects, we maintain that entropy-related measures are indeed informative indices of the quality of a given state of consciousness 10, 11 . An increasing number of studies have reported increased signal complexity, diversity or entropy under psychedelics using a variety of imaging metrics and psychedelic drugs 12, 38, 39 . The increases in signal diversity observed here were associated with the perceived intensity of the experience as well as levels of DMT in plasma.
The neurophenomenological approach and psychometric correlations employed here, using real-time measures and micro-phenomenological interviews, may be seen as a positive step towards the integration of neuronal and first-person reports 19, 40 . The relevant analyses and results allowed us to establish robust and specific relationships between subjective effects (in the visual, somatic and metacognitive/affective domains) and different aspects of the EEG data. Combining multimodal brain imaging (such as using simultaneous EEG-fMRI) with such advancements in subjective data analysis may further aid our understanding of the neural correlates of the psychedelic experience -and indeed other interesting conscious states.
Finally, these results may shed light on some of the neural mechanisms associated to reports showing antidepressant effects of DMT and DMT-containing compounds 41, 42 . Increased alpha band power and decreased delta band power has been found in depressed populations 43 and signal diversity has been found to index fluctuations in mood 44 and depression 45 . It is reasonable to consider that the massive changes in these measures induced by DMT may have implications for modelling and perhaps treating psychopathology.
Some limitations of the present study are worth highlighting. Three different doses of DMT were administered to participants which may have added some variance to our results. Nevertheless, some variance in subjective intensity is useful for correlational analyses. The fixed-order design could be considered a limitation. However, previous psychedelic brain imaging work of ours using fixed-order designs 7 have yielded consistent results with those seen here and may prevent problematic carry-over effects incurred by balanced-order designs, especially when considering the long-lasting psychological effects psychedelics have been shown to have 46 . This is the first report on the resting-state brain effects of intravenous DMT in humans. EEG recordings revealed decreased spectral power in the alpha/beta bands, accompanied by widespread increases in signal diversity. The temporal dynamics of these brain changes closely mirrored the subjective intensity of DMT's effects. An intriguing finding was the observation of an emergent delta/theta rhythmicity during the powerful 'breakthrough' state characteristic of high dose DMT, which was mirrored in time by complex visionary experiences. Further work is now needed to more closely scrutinize this feature of apparent order amidst the background of disorder that has more traditionally been known to characterize the psychedelic state 10, 11 .
The present study's findings significantly advance our understanding of the brain basis of one of the most unusual and intense altered states of consciousness known -a state that has previously been likened to the near-death experience 47 . These findings therefore tell us something important about the neuronal underpinnings of normal consciousness itself -as we can observe what is lost and gained when it transitions in an extreme way -but without the loss of content or awareness. These results may also inform on the nature of analogous states such as dreaming 35, 48 and the experience of dying 47 -and in so doing, advance our appreciation of mind-brain relationships in the broadest range of contexts.
Methods
Participants and Experimental Procedure
Thirteen healthy participants (6 female, 7 male, mean age, 34.4, SD, 9.1 years) were recruited and provided written informed consent for participation in the study, which was approved by the National mg) in a 2 ml sterile saline solution over 30 seconds, which was then flushed with 5 ml of saline over 15 seconds. Administration of placebo (2 ml sterile saline) followed the same procedure as previous studies using intravenous administration of DMT 49, 50 . In order to ensure familiarity with the research environment and study team were ensured by using a fixed-order, single-blind design (placebo on the first visit and DMT on the second, which took place a week later). A fixed-order design was used as psychedelics have been shown to induce lasting psychological changes 46 .
Following administration, blood samples were taken at selected timepoints (which were consistent across DMT and placebo sessions) via a cannula inserted in participants' arm in order to determine DMT levels in plasma. Subjective effects were obtained by asking for intensity ratings in real-time, retrospective Visual Analogue Scales and through 'micro-phenomenological" interviews.
Acquisition of EEG data was done with a 32-channel Brainproducts EEG system (EasycapMR 32) at a sampling rate of 1000Hz. A 0.1 Hz high-pass filter and a 450 Hz anti-aliasing filter was applied.
Additional channels were placed for ECG, EMG and EOG activity, with electrodes placed in the chest, the frontalis and temporalis muscles, as well as placed above and below participants' left eye.
Blood samples of 10 ml were collected in EDTA tubes prior to and at approximately 2, 5, 12, 20, 33 and 60 minutes after DMT administration. Exact sampling times were recorded. After centrifugation at 2500 g for 10 minutes at 4°C, plasma was harvested and frozen at -80°C. Samples were shipped to Gothenburg in dry ice for quantitation of DMT by high-pressure liquid chromatography with tandem masspectrometric detection. In brief, acetonitrile was added to plasma aliquots to precipitate proteins.
After centrifugation at 13 000 g for 10 minutes, 5 µl of supernatant was injected onto the system.
In order to determine the specific progression of effects of DMT over time an independent researcher conducted interviews one day after the DMT session based on the method described by Petitmengin 20, 22 . The Microphenomenological Interview is a technique that is thought to be able to reduce subjective biases particularly affecting first-person reports 20, 21 . It is tailored to facilitate the relationship between subjective experience and its neurophysiological counterparts 22 . Three large dimensions of experience that were common to all participants in the study (visual, bodily and emotional/metacognitive effects) were identified by an independent researcher and subsequently, the intensity of each dimension was rated by the interviewer for every minute using a 4-pont likert scale.
Ratings were then used for neurophenomenological correlations.
Analysis
EEG data was preprocessed using Fieldtrip toolbox 51 . Data was band-pass filtered at 1 -45 Hz and was visually inspected. Data containing gross artefacts (jaw clenches, movement) were removed from further analysis, as well as segments in which ratings of intensity were asked and collected on every minute following drug administration. Independent Component Analysis (ICA) was performed and the components associated to eye movements and muscle activity were removed from the data.
Comparable amount of components was removed across placebo (mean = 5.58, SD = 2.01) and DMT (mean=6.2, SD = 1.66) were removed. Alternative ICA cleaning was performed with less components removed (Placebo mean=4.25 SD =0.92; DMT mean =4.9, SD =0.87), revealing comparable results.
The clean data was then re-referenced to the average of all channels and segmented in trials lasting 3 seconds.
Spectral and spontaneous signal diversity analysis were performed for 5 minutes-averaged data before and immediately after DMT/Placebo administration (time-averaged results). Additionally, we performed analysis using 1 minute averages throughout the whole 20 minutes of EEG recordings following DMT/Placebo injection (time-sensitive results). Conventional spectral analysis was performed using slepian multitapers with spectral smoothing of +/-0.5 Hz using the Fieldtrip toolbox 51 . In order to determine the contribution of oscillatory and 'fractal (1/f) components to spectral power, the signal was decomposed using the Irregularly Resampled AutoSpectral Analysis (IRASA) algorithm, as described by Wen and Liu 14 (see Supplementary Methods for details).
Resulting spectra from both the IRASA algorithm and conventional analysis were divided in the following frequency bands for statistical analysis: Delta (1-4Hz), theta (4-8 Hz), alpha (8-13 Hz), beta (13-30 Hz) and low gamma (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) (41) (42) (43) (44) (45) . We then computed the spontaneous signal diversity following our previous study 13 , thus obtaining a score for Lempel-Ziv complexity (LZs) and a normalized score for LZs (LZsN) in order to ameliorate the effects of spectral power on these results (see Supplementary Methods and Fig. 7 for a schematic on LZs computation). Hz and a length of 1 sec is shown in black (x). The mean (red) of the absolute value of its analytic signal (green, a) is used to binarize the signal (blue). The encoding step of the Lempel-Ziv algorithm is then applied to the first 25 entries of that binarized signal (in this illustration), creating a dictionary of the unique subsequences, which is then normalized by dividing the raw value by those obtained for the same randomly shuffled binary sequence. This provides a value between 0-1 that quantifies the temporal diversity of the EEG signal (LZs).
Statistical Analysis
Paired T-tests were performed at each time point in order to determine the significance of subjective effects determined by real-time intensity ratings and VAS. EEG-related analysis underwent permutation testing of t-statistics to address differences between EEG and placebo. Correlational analyses were performed between 1) Real-time intensity ratings versus EEG measures across time, 2) Plasma DMT versus EEG measures across time, 3) Scores extracted from microphenomenological interviews and EEG measures across time and 4) VAS and EEG measures (Psychometric correlation analysis). Multiple comparison correction was performed using FDR for all subjective effects measures, and cluster randomization analysis was used to control for multiple comparisons of EEG results with an initial cluster-forming threshold of p = 0.05 repeated for 7500 permutations. (see Supplementary Methods for details).
